Literature DB >> 22331096

Prostate cancer: Dutasteride--a welcome addition to active surveillance?

Sarah Payton.   

Abstract

Entities:  

Year:  2012        PMID： 22331096     DOI： 10.1038/nrurol.2012.12

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Authors:  Neil E Fleshner; M Scott Lucia; Blair Egerdie; Lorne Aaron; Gregg Eure; Indrani Nandy; Libby Black; Roger S Rittmaster
Journal:  Lancet       Date:  2012-01-24       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.